ArticleBritish journal of haematology2026
From a novel pathogenic SAMD9L variant to cohort-wide insights: Whole-genome sequencing highlights somatic genetic rescue and phenotypic heterogeneity.
Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Germline gain-of-function variants in sterile alpha motif domain-containing 9-like (SAMD9L), located on chromosome 7q, cause a multisystem disorder characterized by bone marrow failure, immunodeficiency and variable neurological involvement. Disease evolution is frequently shaped by somatic genetic rescue (SGR), most commonly through monosomy 7, somatic loss-of-function (LOF) variants in cis or uniparental disomy of 7q (UPD7q). We report a 6-month-old girl presenting with pancytopenia and severe infections, in whom we identified a novel heterozygous SAMD9L variant. Trio-based whole-genome sequencing demonstrated maternal transmission and revealed distinct SGR mechanisms in both the proband and her asymptomatic mother, including UPD7q and an additional somatic LOF variant. Longitudinal molecular follow-up showed dynamic clonal evolution associated with haematological improvement. To assess the broader relevance of SAMD9/SAMD9L variants, we also performed a gene-centred analysis of the 2025 French Genomic Medicine Initiative (PFMG2025), enabling the identification and classification of additional candidate variants. These findings support systematic screening for SGR, including mosaic UPD7q, even in cases with apparently normal variant allele frequency, and highlight the importance of integrating haematopoietic and non-haematopoietic tissues in diagnostic workflows for inherited bone marrow failure syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.